Sinopharm
1099.HK
#1870
Rank
A$13.77 B
Marketcap
$4.42
Share price
-0.23%
Change (1 day)
24.01%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total debt

Total debt on the balance sheet as of December 2023 : A$16.69 Billion

According to Sinopharm's latest financial reports the company's total debt is A$16.69 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sinopharm - Total debt on balance sheet (from 2008 to 2023)

Total debt by year

Year Total debt Change
2022-12-31A$20.13 B36.06%
2021-12-31A$14.79 B8.31%
2020-12-31A$13.66 B21.2%
2019-12-31A$11.27 B-0.88%
2018-12-31A$11.37 B55.11%
2017-12-31A$7.33 B9.57%
2016-12-31A$6.69 B9.1%
2015-12-31A$6.13 B5.54%
2014-12-31A$5.81 B24.8%
2013-12-31A$4.65 B86.97%
2012-12-31A$2.49 B15.91%
2011-12-31A$2.14 B320.21%
2010-12-31A$0.51 B82.58%
2009-12-31A$0.28 B-17.61%
2008-12-31A$0.33 B-6.53%
2007-12-31A$0.36 B18.91%
2006-12-31A$0.30 B